{"id":"https://openalex.org/W2008037191","doi":"https://doi.org/10.1016/0014-2999(92)90295-f","title":"Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia","display_name":"Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia","publication_year":1992,"publication_date":"1992-08-01","ids":{"openalex":"https://openalex.org/W2008037191","doi":"https://doi.org/10.1016/0014-2999(92)90295-f","mag":"2008037191","pmid":"https://pubmed.ncbi.nlm.nih.gov/1385171"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2999(92)90295-f","doi":"https://doi.org/10.1016/0014-2999(92)90295-f","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(92)90295-f","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael D. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210103024","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210103024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael D. Taylor","raw_affiliation_strings":["Parkinson's Disease Society Experimental Research Laboratories, King's College London, UK","Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parkinson's Disease Society Experimental Research Laboratories, King's College London, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I4210103024"]},{"raw_affiliation_string":"Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I4210103024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055013063","display_name":"Maria L. DE CEBALLOS","orcid":"https://orcid.org/0000-0003-4067-9700","observed_orcids":["https://orcid.org/0000-0003-4067-9700"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210103024","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210103024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Maria L. De Ceballos","raw_affiliation_strings":["Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I4210103024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022335418","display_name":"Sarah Rose","orcid":"https://orcid.org/0000-0003-4723-7665","observed_orcids":["https://orcid.org/0000-0003-4723-7665"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210103024","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210103024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Rose","raw_affiliation_strings":["Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I4210103024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105511214","display_name":"Peter G. Jenner","orcid":"https://orcid.org/0009-0006-0327-7584","observed_orcids":["https://orcid.org/0009-0006-0327-7584"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210103024","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210103024"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter Jenner","raw_affiliation_strings":["Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I4210103024"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112779121","display_name":"C. DAVID MARSDEN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210103024","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210103024"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. David Marsden","raw_affiliation_strings":["Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Sciences Division, King's College London, Manresa Road, London SW3 6LX, UK","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I4210103024"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5105511214"],"corresponding_institution_ids":["https://openalex.org/I183935753","https://openalex.org/I4210103024"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":1.323,"has_fulltext":false,"cited_by_count":58,"citation_normalized_percentile":{"value":0.79648043,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"219","issue":"2","first_page":"183","last_page":"192"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.649399995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.649399995803833,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.2515000104904175,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.050200000405311584,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.9760000109672546},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.8029999732971191},{"id":"https://openalex.org/keywords/carbidopa","display_name":"carbidopa","score":0.8230000138282776},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.7649999856948853},{"id":"https://openalex.org/keywords/basal-ganglia","display_name":"basal ganglia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/neuropeptides","display_name":"neuropeptides","score":0.824999988079071},{"id":"https://openalex.org/keywords/enkephalin","display_name":"enkephalin","score":0.8370000123977661},{"id":"https://openalex.org/keywords/substance-p","display_name":"substance P","score":0.9599999785423279},{"id":"https://openalex.org/keywords/neurotensin","display_name":"neurotensin","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cholecystokinin","display_name":"cholecystokinin","score":1.0},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.7820000052452087},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":1.0},{"id":"https://openalex.org/keywords/medial-forebrain-bundle","display_name":"medial forebrain bundle","score":0.9039999842643738},{"id":"https://openalex.org/keywords/nigrostriatal-pathway","display_name":"nigrostriatal pathway","score":0.8460000157356262},{"id":"https://openalex.org/keywords/dopamine-depletion","display_name":"dopamine depletion","score":0.35199999809265137}],"concepts":[{"id":"https://openalex.org/C2911016594","wikidata":"https://www.wikidata.org/wiki/Q15946111","display_name":"Hydroxydopamine","level":4,"score":0.9779176115989685},{"id":"https://openalex.org/C2777440324","wikidata":"https://www.wikidata.org/wiki/Q4161984","display_name":"Dihydroxyphenylalanine","level":3,"score":0.7612152099609375},{"id":"https://openalex.org/C2778187257","wikidata":"https://www.wikidata.org/wiki/Q464210","display_name":"Basal ganglia","level":3,"score":0.6858017444610596},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.6282022595405579},{"id":"https://openalex.org/C2777288102","wikidata":"https://www.wikidata.org/wiki/Q780181","display_name":"Oxidopamine","level":5,"score":0.625604510307312},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.5331968665122986},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5068688988685608},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5027480125427246},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4055880904197693},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35913538932800293},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.30509448051452637},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.29994481801986694},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.2187696099281311},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.21375501155853271},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.09176903963088989},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08025118708610535},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002230","descriptor_name":"Carbidopa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002766","descriptor_name":"Cholecystokinin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004743","descriptor_name":"Enkephalin, Leucine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004744","descriptor_name":"Enkephalin, Methionine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009479","descriptor_name":"Neuropeptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009496","descriptor_name":"Neurotensin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013373","descriptor_name":"Substance P","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016548","descriptor_name":"Prosencephalon","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016627","descriptor_name":"Oxidopamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2999(92)90295-f","doi":"https://doi.org/10.1016/0014-2999(92)90295-f","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2999(92)90295-f","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:1385171","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1385171","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W110534407","https://openalex.org/W1483520655","https://openalex.org/W1546812311","https://openalex.org/W1905940192","https://openalex.org/W1967552349","https://openalex.org/W1973663703","https://openalex.org/W1974504043","https://openalex.org/W1980604760","https://openalex.org/W1987211745","https://openalex.org/W1987791464","https://openalex.org/W1988041304","https://openalex.org/W1988247408","https://openalex.org/W1988505151","https://openalex.org/W1990157286","https://openalex.org/W1991603311","https://openalex.org/W1998086668","https://openalex.org/W1999494606","https://openalex.org/W2000162399","https://openalex.org/W2002134809","https://openalex.org/W2002932967","https://openalex.org/W2010386338","https://openalex.org/W2012219430","https://openalex.org/W2013080716","https://openalex.org/W2013165553","https://openalex.org/W2017885317","https://openalex.org/W2027675670","https://openalex.org/W2028675219","https://openalex.org/W2028921951","https://openalex.org/W2032040549","https://openalex.org/W2032284020","https://openalex.org/W2032566097","https://openalex.org/W2043254191","https://openalex.org/W2044449613","https://openalex.org/W2046245471","https://openalex.org/W2056203475","https://openalex.org/W2057176173","https://openalex.org/W2058423830","https://openalex.org/W2059577220","https://openalex.org/W2062359923","https://openalex.org/W2062467837","https://openalex.org/W2063030523","https://openalex.org/W2073947145","https://openalex.org/W2073958803","https://openalex.org/W2074322330","https://openalex.org/W2086052746","https://openalex.org/W2087867929","https://openalex.org/W2088614886","https://openalex.org/W2091840632","https://openalex.org/W2092634694","https://openalex.org/W2094704247","https://openalex.org/W2095003706","https://openalex.org/W2097856415","https://openalex.org/W2111090868","https://openalex.org/W2117593813","https://openalex.org/W2139921727","https://openalex.org/W2399402971","https://openalex.org/W2775300358"],"related_works":["https://openalex.org/W2040666748","https://openalex.org/W2068226789","https://openalex.org/W1967552349","https://openalex.org/W2039523359","https://openalex.org/W2009090115","https://openalex.org/W2073958803","https://openalex.org/W2002932967","https://openalex.org/W1678465678","https://openalex.org/W2014438078","https://openalex.org/W1970853027"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}